Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.43 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.39 |
| ▸ | MERTK | Q12866 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CLK1 | P49759 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2950113 | 0.78 | HTT (0.44) | MAPTL3MBTL1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL2941486 | 0.77 | HTT (0.43) | MAPTL3MBTL1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL13234316 | 0.74 | TNKS (0.53) | MAPTL3MBTL1RAB9ANPC1CYP1A2 | |
| SCHEMBL2208450 | 0.69 | AKR1C3 (0.68) | MAPTL3MBTL1RAB9ASMN1; SMN2KMT2A | |
| SCHEMBL2943533 | 0.68 | TNKS (0.49) | MAPTL3MBTL1RAB9AKMT2AMEN1 | |
| SCHEMBL27804983 | 0.68 | MAPT (0.46) | MAPTL3MBTL1RAB9ANPC1KMT2A | |
| SCHEMBL4349056 | 0.68 | AKR1C3 (0.66) | MAPTL3MBTL1RAB9ASMN1; SMN2KMT2A | |
| SCHEMBL5580124 | 0.67 | ALDH1A1 (0.40) | MAPTL3MBTL1NOS1PIK3CAPDE10A | |
| SCHEMBL6814627 | 0.67 | HSD17B10 (0.50) | MAPTNOS1KMT2AMEN1KDM4E | |
| SCHEMBL6740893 | 0.66 | MAPT (0.86) | MAPTL3MBTL1PIK3CARAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7750556-B2 | Triazole derivatives and use thereof in organic light-emitting diodes (OLEDs) | BASF AKTIENGESELLSCHAFT (DE) | 2010-07-06 | — | — | US | disclosed |
| US-7750556-B2 | Triazole derivatives and use thereof in organic light-emitting diodes (OLEDs) | BASF AKTIENGESELLSCHAFT (DE) | 2010-07-06 | — | — | US | disclosed |
| EP-1740673-B1 | TRIAZOLE DERIVATIVES AND USE THEROF IN ORGANIC LIGHT-EMITTING DIODES(OLEDS) | BASF SE (DE) | 2009-12-02 | — | — | EP | disclosed |
| EP-1740673-B1 | TRIAZOLE DERIVATIVES AND USE THEROF IN ORGANIC LIGHT-EMITTING DIODES(OLEDS) | BASF SE (DE) | 2009-12-02 | — | — | EP | disclosed |
| US-20070188078-A1 | Triazole derivatives and use thereof in organic light-emitting diodes (oleds) | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-16 | — | — | US | disclosed |
| US-20070188078-A1 | Triazole derivatives and use thereof in organic light-emitting diodes (oleds) | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070188078-A1 | Triazole derivatives and use thereof in organic light-emitting diodes (oleds) | OCIAD1, OGFOD1, OXA1L | MAPT 1691/4885L3MBTL1 1195/4885NOS1 1411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.